Inference of person-to-person transmission of COVID-19 reveals hidden super-spreading events during the early outbreak phase.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 10 2020
Historique:
received: 11 07 2020
accepted: 10 09 2020
entrez: 7 10 2020
pubmed: 8 10 2020
medline: 21 10 2020
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19) was first identified in late 2019 in Wuhan, Hubei Province, China and spread globally in months, sparking worldwide concern. However, it is unclear whether super-spreading events occurred during the early outbreak phase, as has been observed for other emerging viruses. Here, we analyse 208 publicly available SARS-CoV-2 genome sequences collected during the early outbreak phase. We combine phylogenetic analysis with Bayesian inference under an epidemiological model to trace person-to-person transmission. The dispersion parameter of the offspring distribution in the inferred transmission chain was estimated to be 0.23 (95% CI: 0.13-0.38), indicating there are individuals who directly infected a disproportionately large number of people. Our results showed that super-spreading events played an important role in the early stage of the COVID-19 outbreak.

Identifiants

pubmed: 33024095
doi: 10.1038/s41467-020-18836-4
pii: 10.1038/s41467-020-18836-4
pmc: PMC7538999
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5006

Références

Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Cell Host Microbe. 2015 Oct 14;18(4):398-401
pubmed: 26468744
Euro Surveill. 2015 Jun 25;20(25):7-13
pubmed: 26132767
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32245833
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Lancet Infect Dis. 2015 May;15(5):507-8
pubmed: 25932579
Lancet. 2020 Mar 21;395(10228):949
pubmed: 32087125
Cell. 2018 Mar 8;172(6):1157-1159
pubmed: 29522735
Mol Biol Evol. 2017 Apr 1;34(4):997-1007
pubmed: 28100788
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Science. 2020 May 8;368(6491):638-642
pubmed: 32234804
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Mol Biol Evol. 2017 Nov 1;34(11):2982-2995
pubmed: 28981709
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Mol Biol Evol. 2013 Feb;30(2):239-43
pubmed: 23090976
Emerg Infect Dis. 2013 Jun;19(6):864-9
pubmed: 23731871
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
Nature. 2005 Nov 17;438(7066):355-9
pubmed: 16292310
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Emerg Infect Dis. 2020 Jul;26(7):1628-1631
pubmed: 32240078
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):446-450
pubmed: 32298246
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Lancet. 2020 Mar 14;395(10227):871-877
pubmed: 32087820
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
China CDC Wkly. 2020 Jan 24;2(4):61-62
pubmed: 34594763

Auteurs

Liang Wang (L)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China.

Xavier Didelot (X)

School of Life Sciences and Department of Statistics, University of Warwick, Coventry, CV4 7AL, UK.

Jing Yang (J)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China.

Gary Wong (G)

Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, 200031, China.
Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec City, QC, G1V 0A6, Canada.

Yi Shi (Y)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China.

Wenjun Liu (W)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China.

George F Gao (GF)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China.
University of Chinese Academy of Sciences, Beijing, 101408, China.

Yuhai Bi (Y)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China. beeyh@im.ac.cn.
University of Chinese Academy of Sciences, Beijing, 101408, China. beeyh@im.ac.cn.
Shenzhen Key Laboratory of Pathogen and Immunity, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen Third People's Hospital, Shenzhen, 518112, China. beeyh@im.ac.cn.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH